Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 3 of 3 for “"anti-mitotic agents"”.

  1. Physical Concepts of Copolymerization of Microtubules in the Presence of Anti-mitotic Agents

    … of microtubules in the presence of anti-mitotic drugs is presented in this work. A general feature of the mathematical equations is presented. The possibility of having analytical steady state solutions of dynamic equations is investigated. The structure of equations is narrowed down …

    vt Repository record for Physical Concepts of Copolymerization of Microtubules in the Presence of Anti-mitotic Agents (opens in a new tab)

  2. Synthesis of furo[2,3-d]pyrimidines, thieno[2,3- d]pyrimidines, pyrrolo[2,3-d]pyrimidines as classical and nonclassical antifolates, receptor tyrosine kinase (RTK) inhibitors and antimitotic agents

    … background and research progress in the areas of antifolates, receptor tyrosine kinase (RTK) inhbitors and anti mitotic agents has been discussed. Thymidylate synthase (TS), dihydrofolate reductase (DHFR) and glycinamide ribonucleotide formyltransferase (GARFTase) are important folate dependent …

    duquesne Repository record for Synthesis of furo[2,3-d]pyrimidines, thieno[2,3- d]pyrimidines, pyrrolo[2,3-d]pyrimidines as classical and nonclassical antifolates, receptor tyrosine kinase (RTK) inhibitors and antimitotic agents (opens in a new tab)

  3. Novel combination strategies with Aurora Kinase Inhibitors: using pre-clinical data to guide clinical trial design

    Anti-mitotic drugs such as paclitaxel are successful chemotherapeutics, but their utility is limited by toxicity and resistance. My research aimed to identify novel therapeutic strategies combining current drugs with aurora kinase inhibitors (AKI) in pre-clinical models and then to design a …

    cambridge Repository record for Novel combination strategies with Aurora Kinase Inhibitors: using pre-clinical data to guide clinical trial design (opens in a new tab)